- Prev Rank3
- LocationAnaheim, Calif.
- IndustryPharmaceuticals
- SectorHealth Care
- F1000 Rank-
- G500 Rank-
- Current Streak3
A remarkable transformation from obscure to blockbuster wonder drug: In the early 1990s, anti-inflammatory Acthar Gel sold for $50 per vial. Questor bought rights to the low-key drug in 2001 and began marketing it widely as a wonder drug used to treat kids with severe seizures.
In 2007, Acthar’s price increased from $1,650 to a whopping $23,000 for a 5-milliliter vial. The company explained that the astronomical price hike was needed to keep the drug available on the small, rare diseases market.
Today, a vial costs $28,000 and Questor has seen its annual revenues surge 97% in the past three years. In April, Questor was bought by Dublin-based pharma Mallinckrodt for $5.6 billion. —Vivian Giang
Company Information
Location | Anaheim, Calif. |
Industry | Pharmaceuticals |
Sector | Health Care |
Current Streak | 3 |
Revenue, Net Income
Revenue Past Four Quarters | 891 |
Net Income Past Four Quarters | 327.9 |
Growth Rates & Ranks
EPS Growth Rank | 13 |
EPS 3 yr Annual Growth Rate Pct | 115 |
Revenue Growth Rank | 3 |
Rev 3 yr Annual Growth Rate | 97 |
Total Return 3 yr Annual Rate | 59 |
Total Return Rank | 15 |
Beat S&P 3 yr Annual Growth Rate? | yes |
P/E current fiscal year profits (est.) | 12.7 |